Search Results

You are looking at 181 - 190 of 4,304 items for :

  • "treatment" x
  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All
Interventional Medicine and Applied Science
Authors: Macit Kalçık, Mahmut Yesin, Emrah Bayam, Mustafa Ozan Gürsoy, Ahmet Güner, Sabahattin Gündüz, and Mehmet Özkan

recanalized after thrombolytic therapy (D) Discussion PVT is one of the major causes of prosthetic valve dysfunction. Treatment modalities for PVT include anticoagulation with heparin, TT, and surgery

Open access

to GnRH treatment after emptying of ovarian cysts in dairy cows. Reprod. Domest. Anim. 37 , 294–298. Maffeo G. 17-beta-estradiol, progesterone and testosterone concentrations

Restricted access

recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol., 2012, 23 (Suppl. 7), vii11–vii19. National Comprehensive Cancer Network, Version 3.2013. http

Restricted access
Orvosi Hetilap
Authors: Béla Hunyady, Judit Gervain, Gábor Horváth, Mihály Makara, Alajos Pár, Ferenc Szalay, László Telegdy, and István Tornai

.: Characteristics in treatment organization of chronic hepatitis in Hungary: Hepatitis Registry and Priority Index. [A krónikus vírushepatitisek hazai ellátási rendszerének sajátosságai: Hepatitis Regiszter és a Prioritási Index.] Orv. Hetil., 2013, 154 (29), 1151

Open access

Ferenci P., Bergholz, U., Laferl, H. és mtsai: 24 week treatment regimen with peginterfon α-2a (40 kD) (PEGASYS) plus ribavirin (COPEGUS) in HCV genotype 1 or 4 „super-responders”.; J. Hepatology, 2006, 44 (suppl. 2.) , S6

Restricted access

629 634 McHutchison, J., Gordon, S., Schiff, E. és mtsai: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C

Restricted access

: Long-term follow-up of interferon alpha treatment in Chinese patients with chronic hepatitis B infection: The effect of hepatitis B e antigen seroconversion and the development of cirrhosis related complications. Hepatology, 2001, 34 , 139

Restricted access

90 818 822 Girolami, B., Bernardi, E., Prins, M. H., et al.: Treatment of intermittent claudication with physical training, smoking

Open access
Orvosi Hetilap
Authors: Regina Lukács, Miklós Resch, András Papp, Antal Szabó, Ágnes Borbándy, Hanna Menkens, Huba Kiss, and János Németh

Kourlas, H., Abrams, P.: Ranibizumab for the treatment of neovascular age-related macular degeneration: a review. Clin. Ther., 2007, 29 , 1850–1861. Abrams P. Ranibizumab for the

Open access

Silvestri, G. A., Rivera, P.: Targeted therapy for the treatment of advanced non-small cell lung cancer. A review of the epidermalg growth factor receptor antagonists. Chest, 2005, 12 , 3975–3984. Rivera P

Restricted access